{"product_id":"bd-syringe-05ml-uf-31gx8mm-100","title":"BD Syringe 0.5ml Ultra Fine 31gx8mm 100s","description":"\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"text-decoration: underline; color: #ff2a00;\"\u003ePLEASE NOTE:\u003c\/span\u003e\u003cspan style=\"color: #ff2a00;\"\u003e \u003c\/span\u003eDue to the nature of this product, we cannot accept returns or exchanges for this item. \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThese are only for use with insulin and cannot be sold to under 16s\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe BD insulin syringe with the BD Ultra-Fine™ needle features their shortest insulin syringe needle, at 53% shorter than the 12.7-mm needle. This length is supported by the latest recommendations published in \u003cem\u003eMayo Clinic Proceedings\u003c\/em\u003e that advocate using the shortest needle first-line for all patient categories. In fact, in a 2010 study, 80% of patients preferred shorter needles compared to 8-mm and 12.7-mm needles. They also deliver insulin into the subcutaneous tissue, reducing the risk of painful intramuscular (IM) injection.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe insulin syringe comes in four different barrel sizes and scale capacities to optimize dose\u003c\/li\u003e\n\u003cli\u003eLonger needle lengths may lead to frequent IM vs subcutaneous tissue injections, which may cause unexplained hypoglycemia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e100 syringes in a pack\u003c\/p\u003e","brand":"Kiwi Chemist","offers":[{"title":"Default Title","offer_id":48355120546036,"sku":"2224208","price":29.99,"currency_code":"NZD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0556\/3233\/0904\/files\/SH005_0.5mL_BD_Ultra-Fine_II_Short_Needle_Insulin_Syringe__87533__64862.jpg?v=1780400957","url":"https:\/\/www.kiwichemist.co.nz\/products\/bd-syringe-05ml-uf-31gx8mm-100","provider":"Kiwi Chemist","version":"1.0","type":"link"}